Mirjana Branković-Magić

723 citations
47 papers · 463 indexed · h-index 13
Topics
BRCA gene mutations in cancer (15 papers)Estrogen and related hormone effects (9 papers)Genetic factors in colorectal cancer (7 papers)
Partner nations
SerbiaGreeceCzechia

In The Last Decade

Mirjana Branković-Magić

45 papers receiving 458 citations

Peers

Mirjana Branković-Magić
Comparison fields: 5 of 60
  • Molecular Biology 210
  • Oncology 155
  • Cancer Research 119
  • Genetics 98
  • Otorhinolaryngology 70
Replace Andy Goberdhan with:
Andy Goberdhan United States
Jeffrey P. Bruce Canada
Jason S. White United States
Jos B. Poell Netherlands
Alex F. Carvalho Brazil
Yuuji Nakahara Japan
Noëlla Blétard Belgium
Kinya Baba Japan
Mohamed El Dinali United States
Hey-Chi Hsu Taiwan
Mirjana Branković-Magić relative to Andy Goberdhan United States Andy Goberdhan's profile →
Citations per field
00.5×1.7×
Andy Goberdhan · 1×
Citations per year

Countries citing papers authored by Mirjana Branković-Magić

Since Specialization
Citations

This map shows the geographic impact of Mirjana Branković-Magić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjana Branković-Magić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjana Branković-Magić more than expected).

Fields of papers citing papers by Mirjana Branković-Magić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjana Branković-Magić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjana Branković-Magić. The network helps show where Mirjana Branković-Magić may publish in the future.

Co-authorship network of co-authors of Mirjana Branković-Magić

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjana Branković-Magić. A scholar is included among the top collaborators of Mirjana Branković-Magić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjana Branković-Magić. Mirjana Branković-Magić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 14
3
Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.
12
4 14
5 4
6 20
7 6
8 11
9 47
10 14
11 7
12 4
13 61
14 58
15 15
16
PS2 protein in breast carcinomas: cut-off value of estrogen-regulated expression.
2
17
Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
3
18
Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.
15
19 9
20 14

About Mirjana Branković-Magić

Mirjana Branković-Magić is a scholar working on Otorhinolaryngology, Genetics and Cancer Research, having authored 47 papers that have together received 463 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (15 papers), Estrogen and related hormone effects (9 papers) and Genetic factors in colorectal cancer (7 papers). The work is most often cited by research in Otorhinolaryngology (70 citations), Cancer Research (119 citations) and Periodontics (28 citations). Mirjana Branković-Magić has collaborated with scholars based in Serbia, Greece and Czechia. Frequent co-authors include Zvonko Magić, Ružica Kozomara, Nebojša Jović, Ana Krivokuća, Gordana Šupić, Siniša Radulović, Dragica Nikolić‐Vukosavljević, Radmila Janković, Emina Mališić and I Spuz̈ić. Their work appears in journals such as BMC Cancer, Oral Oncology and Acta Oncologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026